Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00405613Phase 2Completed
Phase 2, randomised, double-blind trial in cardiovascular diseases (CVD) comparing Aspirin with Placebo (2 arms). Primary endpoint: Oral bleeding time. Started May 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00405613.